Go to AAD Home
Donate For Public and Patients Store Search

Go to AAD Home
Welcome!
Advertisement
Advertisement

July 14, 2021


IN THIS ISSUE / July 14, 2021


Acne scarring treatments: What’s most effective?

According to a study presented at AAD VMX 2021, subcision, medium-to-deep chemical peels, and ablative and non-ablative fractional lasers offered the best outcomes for acne scarring. The researchers performed a meta-analysis of 48 studies related to acne scarring treatments.

Subcision was found to have a mean improvement in acne scar appearance of 61%, followed by medium-to-deep chemical peels at 53%, and ablative lasers at nearly 50%. Patients who received cold microneedling experienced the most improvement at four weeks, with 97% experiencing fair improvement and 48% with good improvement. However, these percentages decreased to 77% and 27% at 12 weeks.

Access to AAD VMX 2021 on-demand content has been extended through Oct. 15. Register now to watch sessions.

Related content:


Headshot for Dr. Warren R. Heymann
DermWorld Insights and Inquiries: Assessing the significance of a Long-Developed Habit — The role of LDH in dermatology

Upon ordering laboratory tests recently for a patient with cutaneous T cell lymphoma, I included a lactate dehydrogenase (LDH) level, as I have done for decades, without giving it much thought. When I came across an article titled “Lactate dehydrogenase in dermatology practice” by Livesey et al, I asked myself, why have I been ordering an LDH? Is it just a habit? What am I looking for? What is its utility? Is it worth obtaining? Keep reading!


Derm Coding Consult: Applying 2021 E/M coding concepts in everyday practice – Part 6

Part six of the AADA’s clinical vignettes focuses on the application of coding concepts related to E/M encounters. These clinical vignettes demonstrate how a single condition can be categorized under different categories of problems addressed during the encounter depending on disease severity and patient presenting circumstances at the time of the encounter. Review the next three coding vignettes.


Share your comments on the AD comorbidity guideline

The AAD is seeking member comments on its draft clinical practice guideline on comorbidities associated with atopic dermatitis (AD). These guidelines appraise evidence of the association between AD and selected comorbidities among adults. Feedback received will be provided to the guideline development workgroup for review. Submit your comments by July 19.


CMS makes sweeping changes to MIPS quality benchmarks

In June 2021, CMS announced that it has made sweeping changes to many of the MIPS quality measure benchmarks due to an across-the-board error it uncovered. The correction caused the range of performance rates for a given decile to be shifted down one decile. The Academy’s quality measure webpages and informational page regarding the quality category have been updated to reflect these changes.

Additionally, do not forget about the two exception applications available to eligible clinicians in the 2021 performance year: MIPS Promoting Interoperability Performance Category Hardship Exception and Extreme and Uncontrollable Circumstances Exception (such as the COVID-19 pandemic) that allow re-weighting for meeting approved criteria. For additional information and guidance, visit staging.aad.org/mips.


JAAD ranks No. 1 among dermatology journals

The Journal of the American Academy of Dermatology is the top peer-reviewed journal in its field, according to the 2020 impact factor rankings published by Clarivate’s Journal Citation Reports (JCR) Web of Science Group.

A journal’s impact factor reflects how often the average article in that journal has been cited in a given time period, which for JCR is two years. JAAD’s 2020 impact factor of 11.527 is a 40% increase over its previous ranking. This places the journal in the No. 1 position among 89 dermatology journals ranked by JCR. Read more.

Advertisement

The American Academy of Dermatology is a non-profit professional organization and does not endorse companies or products. Advertising helps support our mission.

Opportunities

Advertising | Sponsorship

Advertisement
Advertisement
Advertisement